Age Rating
Cancer Risk Screenshots
About Cancer Risk
The Rotterdam Prostate Cancer Risk Calculator is based on ERSPC, Rotterdam, data and supported by the Prostate Cancer Research Foundation, Rotterdam (SWOP)
The Prostate Cancer Research Foundation, Rotterdam, Stichting Wetenschappelijk Onderzoek Prostaatkanker (SWOP), is an initiative of the Department of Urology of the Erasmus MC, the University and Medical Centre of Rotterdam, in The Netherlands. Its goal is the financial support of scientific research projects in the field of prostate cancer, as well as other cancers of the urinary tract.
Please be aware that the Rotterdam Prostate Cancer Risk Calculator for iOS cannot be 100% accurate at predicting the presence or absence of prostate cancer. It is designed to help calculate your risk, not give a definitive diagnosis.
The Rotterdam Prostate Cancer Risk Calculator for iOS provides a general risk calculation based on your PSA level and other information.
While knowing your PSA level is helpful, the decision to have a PSA test has to be taken seriously after weighing up all factors and discussing the implications with your GP or hospital doctor.
It is possible that prostate cancer will not be found even if you have an elevated PSA. However, it may be present even if your PSA level is low.
Your doctor may want to take further tests. If you have doubts or questions about your health, you should always contact your GP or hospital doctor. This is particularly important if you have questions which arise from the use of our prostate cancer risk calculator.
It cannot be ruled out that the way the Rotterdam Prostate Cancer Risk Calculator for iOS is used, or the indications given by it, are interpreted in a manner that is not appropriate. The creators of the Rotterdam Prostate Cancer Risk Calculator for iOS do not accept any responsibility in any respect.
The European Randomized Study of Screening for Prostate Cancer has published its 11-year follow-up results (New England Journal of Medicine, March 15 2012). Once again, they demonstrate that screening does significantly reduce death from prostate cancer. The latest study confirms that a man who undergoes PSA testing will have his risk of dying from prostate cancer reduced by 29%.
ERSPC is the world’s largest randomized prostate cancer screening study. It was designed to investigate whether early detection and treatment of prostate cancer might reduce disease-specific mortality and also help to identify men at risk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to 69, across Europe to either a screening arm or a control group.
Designed and developed for iOS by Nuno Azevedo of Ydeal.net Software LDA
The Prostate Cancer Research Foundation, Rotterdam, Stichting Wetenschappelijk Onderzoek Prostaatkanker (SWOP), is an initiative of the Department of Urology of the Erasmus MC, the University and Medical Centre of Rotterdam, in The Netherlands. Its goal is the financial support of scientific research projects in the field of prostate cancer, as well as other cancers of the urinary tract.
Please be aware that the Rotterdam Prostate Cancer Risk Calculator for iOS cannot be 100% accurate at predicting the presence or absence of prostate cancer. It is designed to help calculate your risk, not give a definitive diagnosis.
The Rotterdam Prostate Cancer Risk Calculator for iOS provides a general risk calculation based on your PSA level and other information.
While knowing your PSA level is helpful, the decision to have a PSA test has to be taken seriously after weighing up all factors and discussing the implications with your GP or hospital doctor.
It is possible that prostate cancer will not be found even if you have an elevated PSA. However, it may be present even if your PSA level is low.
Your doctor may want to take further tests. If you have doubts or questions about your health, you should always contact your GP or hospital doctor. This is particularly important if you have questions which arise from the use of our prostate cancer risk calculator.
It cannot be ruled out that the way the Rotterdam Prostate Cancer Risk Calculator for iOS is used, or the indications given by it, are interpreted in a manner that is not appropriate. The creators of the Rotterdam Prostate Cancer Risk Calculator for iOS do not accept any responsibility in any respect.
The European Randomized Study of Screening for Prostate Cancer has published its 11-year follow-up results (New England Journal of Medicine, March 15 2012). Once again, they demonstrate that screening does significantly reduce death from prostate cancer. The latest study confirms that a man who undergoes PSA testing will have his risk of dying from prostate cancer reduced by 29%.
ERSPC is the world’s largest randomized prostate cancer screening study. It was designed to investigate whether early detection and treatment of prostate cancer might reduce disease-specific mortality and also help to identify men at risk. From 1992, the ERSPC study randomized 162,000 men, aged 55 to 69, across Europe to either a screening arm or a control group.
Designed and developed for iOS by Nuno Azevedo of Ydeal.net Software LDA
Show More
Was ist neu in der neuesten Version 3.2.3
Last updated on Sep 22, 2020
Alte Versionen
Bug Fixed
Show More
Version History
3.2.3
Sep 22, 2020
Bug Fixed
3.2.2
Jul 22, 2020
Update About
3.2.1
May 5, 2020
Bug Fixed
3.2.0
Apr 1, 2020
Verbesserung der Berechnung
3.1.2
Apr 10, 2019
Neues über
3.1.1
Oct 13, 2018
Information hinzufügen
3.1.0
Sep 4, 2018
MRI ist die Abkürzung für Magnetic Resonance Imaging. Ein MRI von der Prostata wird beurteilt nach den PIRADS System. PIRADS 1 weist auf die gutartigste und PIRADS 5 auf die bösartigste Form von Prostatakrebs. Für diesen Rechner wurde PIRADS Version 1 gebraucht.
2.6.6
Mar 1, 2018
Bug fixed
2.6.5
Jan 12, 2018
Bug fixed
2.6.4
Jan 11, 2018
Bug fix
2.6.3
Jan 5, 2018
support for iPhone X and bug fix
2.6.2
Nov 4, 2017
support for iPhone X
2.6.1
Nov 29, 2016
Bug fixed - Estonian language
2.6
Sep 26, 2016
Includes support for Estonian language
2.5
Oct 29, 2015
In-App language selection;
Send your results by email to your doctor.
Send your results by email to your doctor.
2.1
Oct 20, 2014
Minor issues fixed.
Add Chinese, Spanish and Portuguese languages.
Add Chinese, Spanish and Portuguese languages.
2.0
Apr 3, 2014
Add iPad support and improve performance.
1.2
Dec 5, 2013
This version is now compatible with previous iOS versions (pre-iOS7).
1.1
Nov 10, 2013
Updated algorithm!
1.0
Oct 25, 2013
Cancer Risk Preis
Heute:
1,99 €
Am günstigsten:
1,99 €
Am teuersten:
2,49 €
Cancer Risk FAQ
Klicken Sie hier, um zu erfahren, wie Sie Cancer Risk in eingeschränkten Ländern oder Regionen herunterladen können.
Überprüfen Sie die folgende Liste, um die Mindestanforderungen von Cancer Risk zu sehen.
iPhone
Erfordert iOS 9.3 oder neuer.
iPad
Erfordert iPadOS 9.3 oder neuer.
iPod touch
Erfordert iOS 9.3 oder neuer.
Cancer Risk unterstützt Deutsch, Englisch, Estnisch, Niederländisch, Portugiesisch, Spanisch, Vereinf. Chinesisch